Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
US7790756B2 · kind B2 · utility
66Cited by
35References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 10, 2007 |
| Grant date | Sep 7, 2010 |
| Priority date | — |
| Expiry date | Oct 10, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is concerned with novel compounds useful in the treatment of hyperproliferative diseases and mammalian cancers, especially human cancers. The invention also pertains to methods of modulating kinase activities, pharmaceutical compositions, and methods of treating individuals, incorporating or using the compounds. The preferred compounds are active small molecules set forth in formulae Ia-Iww.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.